海洋生物技术市场规模、份额、成长分析、按类型、技术、应用、最终用户、地区 - 产业预测，2025-2032 年

2023 年全球海洋生物技术市场规模价值 65 亿美元，预计将从 2024 年的 69.5 亿美元成长到 2032 年的 118.5 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.9%。

全球海洋生物技术市场正在崛起，利用海洋资源彻底改变医疗、农业和能源领域。这个快速成长的产业是由对永续和环保替代品的需求、慢性病的增加以及对再生能源来源的追求所驱动。然而，研发成本高、海洋资源取得管道有限以及监管障碍等挑战阻碍了快速成长。然而，生物技术和基因组学的进步以及产学研合作的不断加强将有助于扩大市场。全球主要趋势包括在工业过程中采用海洋酶以及对用于医疗和组织工程应用的海洋生医材料的兴趣日益浓厚，这表明在全球永续性要求日益提高的背景下，存在巨大的增长和创新机会。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

海洋生物技术市场规模（按类型）

• 市场概况
• 生物活性物质
• 生医材料

海洋生物技术市场规模（依技术划分）

• 市场概况
• 微生物分离与培养
• 文化独立的技术

海洋生物技术市场规模（按应用）

• 市场概况
• 水产养殖和食品
• 环境与人类健康
• 药物研发

海洋生物技术市场规模（按最终用户划分）

• 市场概况
• 食品工业
• 製药和生物技术产业
• 化工
• 化妆品产业

海洋生物技术市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• BASF（Germany）
• Key Developments
• Cyanotech Corp.（USA）
• Kerry Group（Ireland）
• Corbion（Netherlands）
• FMC Corp.（USA）
• Marine Biotech（USA）
• Royal DSM（Netherlands）
• TransGen Biotech Co., Ltd.（China）
• Olmix Group（France）
• Ittinsect（Italy）
• BRAIN Biotech AG（Germany）
• Biotech Marine（France）
• Marinova Pty Ltd（Australia）
• Pharma Mar, SA（Spain）
• GlycoMar Ltd.（UK）
• Aker BioMarine ASA（Norway）
• oceanBASIS GmbH（Germany）
• Primex Iceland（Iceland）
• New England Biolabs（NEB）（USA）

结论和建议

Global Marine Biotechnology Market size was valued at USD 6.5 billion in 2023 and is poised to grow from USD 6.95 billion in 2024 to USD 11.85 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global marine biotechnology market is on an upward trajectory, leveraging oceanic resources to innovate in medicine, agriculture, and energy sectors. This burgeoning industry is driven by the demand for sustainable, eco-friendly alternatives, heightened chronic disease prevalence, and the pursuit of renewable energy sources. Yet, challenges such as high R&D costs, limited access to marine resources, and regulatory barriers impede rapid growth. Nonetheless, advancements in biotechnology and genomics, along with rising collaborations between industry and research organizations, are poised to propel market expansion. Key trends include the adoption of marine-derived enzymes in industrial processes and a growing interest in marine biomaterials for applications in medicine and tissue engineering, suggesting significant opportunities for growth and innovation as global sustainability imperatives intensify.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Marine Biotechnology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Marine Biotechnology Market Segments Analysis

Global Marine Biotechnology Market is segmented by Type, Technology, Application, End-user and region. Based on Type, the market is segmented into Bio Active Substance and Bio Materials. Based on Technology, the market is segmented into Isolation and Cultivation of Microorganisms and Culture-Independent Techniques. Based on Application, the market is segmented into Aquaculture and Food Products, Environment & Human Health and Drug Discovery. Based on End-user, the market is segmented into Food Industry, Pharmaceutical and Biotechnology Industry, Chemical Industry and Cosmetic Industry. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Marine Biotechnology Market

Rising awareness of environmental issues and the push for sustainability are driving demand for eco-friendly products in numerous sectors. Marine biotechnology emerges as a key player in this movement, providing sustainable solutions like marine-derived enzymes for industrial uses, alongside biofuels and bioplastics. One notable example is Algix, a company that creates biodegradable bioplastic materials sourced from algae, presenting a sustainable alternative to conventional plastics. The integration of these innovative marine-derived solutions is not only addressing ecological concerns but also promoting a transition towards greener practices across various industries, highlighting the significant role of marine biotechnology in the global market.

Restraints in the Global Marine Biotechnology Market

The Global Marine Biotechnology market faces significant limitations due to the extensive research and development required for product innovation. This process includes identifying and cultivating marine organisms, alongside extracting and purifying bioactive compounds. Such intricate procedures come with high costs, which can hinder the growth and commercialization of marine biotechnology products. For instance, the cultivation and extraction of just one marine-derived compound can incur expenses totaling several hundred thousand dollars. This financial challenge poses a barrier for many companies seeking to enter and thrive in the market, ultimately impacting the industry's overall expansion and profitability.

Market Trends of the Global Marine Biotechnology Market

The Global Marine Biotechnology market is witnessing a significant trend towards the utilization of marine-derived biomaterials, driven by their unique properties and diverse applications in medicine, tissue engineering, and regenerative therapies. Innovations such as marine collagen, noted for its enhanced biocompatibility and biological functionality compared to traditional mammalian alternatives, are gaining traction in wound healing and tissue regeneration processes. The shift towards sustainable and biodegradable materials, coupled with increased research and development efforts, is propelling the demand for these biomaterials. This emerging trend highlights the potential of marine resources to revolutionize healthcare solutions and drive growth within the marine biotechnology sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Marine Biotechnology Market Size by Type & CAGR (2025-2032)

• Market Overview
• Bio Active Substance
• Bio Materials

Global Marine Biotechnology Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Isolation and Cultivation of Microorganisms
• Culture-Independent Techniques

Global Marine Biotechnology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Aquaculture and Food Products
• Environment & Human Health
• Drug Discovery

Global Marine Biotechnology Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Food Industry
• Pharmaceutical and Biotechnology Industry
• Chemical Industry
• Cosmetic Industry

Global Marine Biotechnology Market Size & CAGR (2025-2032)

• North America (Type, Technology, Application, End-user)
  • US
  • Canada
• Europe (Type, Technology, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Technology, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Technology, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Technology, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• BASF (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Cyanotech Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corbion (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FMC Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marine Biotech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TransGen Biotech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olmix Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ittinsect (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BRAIN Biotech AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotech Marine (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marinova Pty Ltd (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharma Mar, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlycoMar Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aker BioMarine ASA (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• oceanBASIS GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Primex Iceland (Iceland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (NEB) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations